Table 1 Baseline characteristics of the sample under study
Benign | Borderline | Malignant | ||
|---|---|---|---|---|
Number | n(%) | 120 (77.4) | 8 (5.2) | 27 (17.4) |
Age (years) | Median (range) | 38 (14–78) | 37.5 (24–61) | 52 (23–72) |
Postmenopausal status | n(%) | 21 (17.5) | 2 (25) | 19 (70.4) |
RMI1 | Median (range) | 18.03 (0–1679) | 23.06 (0–156) | 340.80 (0–19,224) |
RMI2 | Median (range) | 35.94 (4.15–1679) | 57.48 (11.07–277.92) | 454.4 (12.67–34,176) |
RMI3 | Median (range) | 31.65 (4.15–1679) | 48.49 (11.07–158.4) | 340.8 (12.67–19,224) |
RMI4 | Median (range) | 52.02 (4.15–3358) | 77.80 (11.07–555.84) | 908.80 (12.67–68,352) |
ROMA | Median (range) | 5.9 (1.6–28.5) | 8.2 (3.2–60.9) | 34.6 (4–99.1) |
HE4 pmol/l | Median (range) | 42.17 (25.37–123) | 47.03 (34.47–163.30) | 57.59 (35.57- > 1500) |